Nalaganje...

Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design

The quest for an effective HIV-1 vaccine began as soon as the virus causing AIDS was identified. After several disappointing attempts, results of the Phase-III RV144 trial in Thailand were a beacon of hope for the field demonstrating correlation between protection and immunological markers. In order...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:AIDS Res Ther
Main Authors: Routy, Jean-Pierre, Mehraj, Vikram
Format: Artigo
Jezik:Inglês
Izdano: BioMed Central 2017
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5594512/
https://ncbi.nlm.nih.gov/pubmed/28893288
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12981-017-0164-9
Oznake: Označite
Brez oznak, prvi označite!